Detalhe da pesquisa
1.
Redirecting the specificity of tripartite motif containing-21 scaffolds using a novel discovery and design approach.
J Biol Chem
; 299(12): 105381, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37866632
2.
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
J Autoimmun
; 140: 103125, 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844543
3.
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
BioDrugs
; 38(2): 227-248, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999893
4.
Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach.
Cell Rep Methods
; 3(3): 100429, 2023 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056366
5.
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis.
Sci Adv
; 9(22): eadd8693, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37267370
6.
IL-2 can signal via chemokine receptors to promote regulatory T cells' suppressive function.
Cell Rep
; 42(8): 112996, 2023 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598341
7.
Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response.
Sci Immunol
; 8(87): eadg1487, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713507
8.
Biologics-based degraders - an expanding toolkit for targeted-protein degradation.
Curr Opin Biotechnol
; 78: 102807, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179405
9.
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
Cell Rep
; 41(3): 111478, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261022
10.
Remotely Triggered Nano-Theranostics For Cancer Applications.
Nanotheranostics
; 1(1): 1-22, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28191450
11.
Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer.
Oncomedicine
; 2: 1-13, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28174679